To gain a deeper understanding of the underlying mechanism behind the immune suppression of CD27 signaling, we investigated the association between CD27 expression and a variety of immunological checkpoint markers in 33 different cancer types (Figure 8C). The gene discussed is CD27; the disease is cancer.